scispace - formally typeset
B

Bryan Kestenbaum

Researcher at University of Washington

Publications -  278
Citations -  15620

Bryan Kestenbaum is an academic researcher from University of Washington. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 64, co-authored 249 publications receiving 13250 citations. Previous affiliations of Bryan Kestenbaum include Fred Hutchinson Cancer Research Center & University of Washington Medical Center.

Papers
More filters
Journal ArticleDOI

Kidney Disease and Increased Mortality Risk in Type 2 Diabetes

TL;DR: Those with kidney disease predominantly account for the increased mortality observed in type 2 diabetes, and similar patterns for cardiovascular and noncardiovascular mortality are observed.
Journal ArticleDOI

Effects of Phosphate Binders in Moderate CKD

TL;DR: In conclusion, phosphate binders significantly lower serum and urinary phosphorus and attenuate progression of secondary hyperparathyroidism among patients with CKD who have normal or near-normal levels of serum phosphorus; however, they also promote the progression of vascular calcification.
Journal ArticleDOI

Vitamin D and the risk of dementia and Alzheimer disease

TL;DR: It is confirmed that vitamin D deficiency is associated with a substantially increased risk of all-cause dementia and Alzheimer disease, and adds to the ongoing debate about the role of vitamin D in nonskeletal conditions.
Journal ArticleDOI

Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKD

TL;DR: Higher serum phosphate concentrations are associated with a greater prevalence of vascular and valvular calcification in people with moderate CKD, and it remains to be determined whether lowering phosphate concentrations will impact calcification risk in the setting of kidney disease.
Journal ArticleDOI

Elevated risk of stroke among patients with end-stage renal disease

TL;DR: Although prior public health initiatives have focused primarily on cardiac disease among patients treated with dialysis, the data suggest that new initiatives are needed to control the high risk of stroke in this population of dialysis patients.